Latest Judah Folkman Stories

New Microdevice Enables Culture Of Rare Circulating Tumor Cells From Blood
2012-04-24 13:31:25

Ability to culture rare tumor cells isolated from blood could help improve patient response to therapy A research collaboration between the Wyss Institute for Biologically Inspired Engineering at Harvard University and Children´s Hospital Boston has created a microfluidic device that can harvest rare circulating tumor cells (CTCs) from blood to enable their expansion in culture for analysis. These cells, which have detached from a primary cancer site and often create a secondary --...

2011-08-18 12:27:00

CAMBRIDGE, Mass., Aug. 18, 2011 /PRNewswire/ -- Leading angiogenesis and cancer researcher Dr. Robert S. Kerbel of the University of Toronto will deliver the Future of Medicine Keynote Address at the Angiogenesis Foundation's 9th International M. Judah Folkman Conference -- New Frontiers in Therapeutic Development. The conference will take place on October 29-30, 2011 in Cambridge, MA, and attracts key opinion leaders from academia, industry and government to discuss the latest scientific...

2011-05-11 09:12:00

CAMBRIDGE, Mass., May 11, 2011 /PRNewswire/ -- The Angiogenesis Foundation has opened early registration for its 2011 Antiangiogenesis Conference that will take place on October 29-30 in Cambridge, MA. The 9th International M. Judah Folkman Conference -- New Frontiers in Therapeutic Development attracts key opinion leaders from academia, industry, government, and patient advocacy to discuss the latest information about research and therapeutic development in antiangiogenic therapy for...

2009-06-09 13:44:30

 To grow and spread, tumors need new blood vessels, a process called angiogenesis. One growth factor that causes angiogenesis has been identified -  vascular endothelial growth factor or  VEGF - and drugs to inhibit VEGF are already in use. But not all tumors respond to the therapy initially or over the long term. Thus new growth factors need to be identified to aid in developing the next generation of angiogenesis inhibitors.Scientists at the UNC Lineberger Comprehensive...

2009-05-20 14:13:20

Research in mice and human stem cells suggests new therapeutic targets Most cancers are rare in people with Down syndrome, whose overall cancer mortality is below 10 percent of that in the general population. Since they have an extra copy of chromosome 21, it's been proposed that people with Down syndrome may be getting an extra dose of one or more cancer-protective genes. The late cancer researcher Judah Folkman, MD, founder of the Vascular Biology Program at Children's Hospital Boston,...

Word of the Day
  • The prevailing range of a vocal or instrumental part, within which most of the tones lie.
This word is Italian in origin and comes from the Latin 'textura,' web, structure.